1. Home
  2. APRE vs SOAR Comparison

APRE vs SOAR Comparison

Compare APRE & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • SOAR
  • Stock Information
  • Founded
  • APRE 2006
  • SOAR 2021
  • Country
  • APRE United States
  • SOAR United States
  • Employees
  • APRE N/A
  • SOAR N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • SOAR Blank Checks
  • Sector
  • APRE Health Care
  • SOAR Finance
  • Exchange
  • APRE Nasdaq
  • SOAR Nasdaq
  • Market Cap
  • APRE 8.3M
  • SOAR 9.4M
  • IPO Year
  • APRE 2019
  • SOAR N/A
  • Fundamental
  • Price
  • APRE $1.47
  • SOAR $2.02
  • Analyst Decision
  • APRE Strong Buy
  • SOAR
  • Analyst Count
  • APRE 1
  • SOAR 0
  • Target Price
  • APRE $20.00
  • SOAR N/A
  • AVG Volume (30 Days)
  • APRE 40.4K
  • SOAR 1.1M
  • Earning Date
  • APRE 11-06-2025
  • SOAR 11-17-2025
  • Dividend Yield
  • APRE N/A
  • SOAR N/A
  • EPS Growth
  • APRE N/A
  • SOAR N/A
  • EPS
  • APRE N/A
  • SOAR N/A
  • Revenue
  • APRE $841,012.00
  • SOAR $96,397,000.00
  • Revenue This Year
  • APRE N/A
  • SOAR N/A
  • Revenue Next Year
  • APRE N/A
  • SOAR N/A
  • P/E Ratio
  • APRE N/A
  • SOAR N/A
  • Revenue Growth
  • APRE N/A
  • SOAR 309.80
  • 52 Week Low
  • APRE $1.37
  • SOAR $1.14
  • 52 Week High
  • APRE $5.01
  • SOAR $19.06
  • Technical
  • Relative Strength Index (RSI)
  • APRE 45.12
  • SOAR 64.87
  • Support Level
  • APRE $1.46
  • SOAR $1.70
  • Resistance Level
  • APRE $1.57
  • SOAR $2.25
  • Average True Range (ATR)
  • APRE 0.08
  • SOAR 0.18
  • MACD
  • APRE 0.01
  • SOAR 0.04
  • Stochastic Oscillator
  • APRE 54.45
  • SOAR 70.55

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About SOAR Volato Group Inc.

Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

Share on Social Networks: